Impact of Nasopharyngeal Specimen Quality on SARS-CoV-2 Test Sensitivity.
Melissa Richard-GreenblattMatthew J ZieglerValerie BrombergElizabeth HuangHatem AbdallahPam TolomeoEbbing LautenbachLaurel GlaserBrendan J KellyPublished in: medRxiv : the preprint server for health sciences (2020)
Variability in NP specimen quality accounts for significant differences in the sensitivity of clinical SARS-CoV-2 assays. If unrecognized, low quality NP specimens, which are characterized by a low level of amplifiable human DNA target, may limit the application of SARS-CoV-2 Ct values to direct infection control and public health interventions.